Logo image of AIH

AESTHETIC MEDICAL INTERN-ADR (AIH) Stock Fundamental Analysis

NASDAQ:AIH - Nasdaq - US00809M1045 - ADR - Currency: USD

0.3334  -0.17 (-33.19%)

After market: 0.3338 +0 (+0.12%)

Fundamental Rating

1

AIH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AIH have multiple concerns. AIH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AIH had negative earnings in the past year.
AIH had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AIH reported negative operating cash flow in multiple years.
AIH Yearly Net Income VS EBIT VS OCF VS FCFAIH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -13.58%, AIH is doing worse than 74.78% of the companies in the same industry.
AIH has a worse Return On Equity (-178.21%) than 81.74% of its industry peers.
Industry RankSector Rank
ROA -13.58%
ROE -178.21%
ROIC N/A
ROA(3y)-46.1%
ROA(5y)-32.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AIH Yearly ROA, ROE, ROICAIH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 200 -200 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 48.96%, AIH is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of AIH has declined.
The Profit Margin and Operating Margin are not available for AIH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.04%
GM growth 5Y-4.38%
AIH Yearly Profit, Operating, Gross MarginsAIH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 50 -50

More info and screens

0

2. Health

2.1 Basic Checks

AIH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AIH has more shares outstanding
AIH has a worse debt/assets ratio than last year.
AIH Yearly Shares OutstandingAIH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
AIH Yearly Total Debt VS Total AssetsAIH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

AIH has an Altman-Z score of -2.28. This is a bad value and indicates that AIH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.28, AIH is not doing good in the industry: 81.74% of the companies in the same industry are doing better.
AIH has a Debt/Equity ratio of 3.91. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AIH (3.91) is worse than 75.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.91
Debt/FCF N/A
Altman-Z -2.28
ROIC/WACCN/A
WACC5.49%
AIH Yearly LT Debt VS Equity VS FCFAIH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.35 indicates that AIH may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.35, AIH is doing worse than 92.17% of the companies in the same industry.
AIH has a Quick Ratio of 0.35. This is a bad value and indicates that AIH is not financially healthy enough and could expect problems in meeting its short term obligations.
AIH has a worse Quick ratio (0.29) than 93.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.29
AIH Yearly Current Assets VS Current LiabilitesAIH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

AIH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.54%, which is quite impressive.
AIH shows a small growth in Revenue. In the last year, the Revenue has grown by 3.79%.
The Revenue has been decreasing by -0.80% on average over the past years.
EPS 1Y (TTM)89.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)3.79%
Revenue growth 3Y-8.3%
Revenue growth 5Y-0.8%
Sales Q2Q%-4.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AIH Yearly Revenue VS EstimatesAIH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M
AIH Yearly EPS VS EstimatesAIH Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIH Price Earnings VS Forward Price EarningsAIH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AIH is valued a bit cheaper than 65.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.49
AIH Per share dataAIH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AESTHETIC MEDICAL INTERN-ADR

NASDAQ:AIH (5/20/2024, 8:18:23 PM)

After market: 0.3338 +0 (+0.12%)

0.3334

-0.17 (-33.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-15 2024-05-15/bmo
Earnings (Next)09-03 2024-09-03
Inst Owners0.04%
Inst Owner Change-88.71%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.93M
Analysts80
Price Target10.2 (2959.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 2.51
P/tB 12.27
EV/EBITDA 13.49
EPS(TTM)-0.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.88
BVpS0.13
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.58%
ROE -178.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.96%
FCFM N/A
ROA(3y)-46.1%
ROA(5y)-32.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.04%
GM growth 5Y-4.38%
F-ScoreN/A
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 3.91
Debt/FCF N/A
Debt/EBITDA 8.6
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.29
Altman-Z -2.28
F-ScoreN/A
WACC5.49%
ROIC/WACCN/A
Cap/Depr(3y)26.3%
Cap/Depr(5y)62.68%
Cap/Sales(3y)3.48%
Cap/Sales(5y)5.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.79%
Revenue growth 3Y-8.3%
Revenue growth 5Y-0.8%
Sales Q2Q%-4.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y93.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-535.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-247.05%
OCF growth 3YN/A
OCF growth 5YN/A